2014 Q1 Form 10-K Financial Statement
#000120037514000011 Filed on March 13, 2014
Income Statement
| Concept | 2014 Q1 | 2013 Q4 | 2013 |
|---|---|---|---|
| Revenue | $7.074M | $9.525M | $31.92M |
| YoY Change | -38.39% | 20.39% | -63.85% |
| Cost Of Revenue | $2.524M | $4.764M | $14.55M |
| YoY Change | -55.45% | -17.56% | -52.51% |
| Gross Profit | $4.550M | $4.761M | $17.37M |
| YoY Change | -21.77% | 123.21% | -69.87% |
| Gross Profit Margin | 64.32% | 49.98% | 54.41% |
| Selling, General & Admin | $6.112M | $5.783M | $26.91M |
| YoY Change | -24.77% | -20.63% | -14.25% |
| % of Gross Profit | 134.33% | 121.47% | 154.93% |
| Research & Development | $4.834M | $8.829M | $31.61M |
| YoY Change | -33.98% | -16.66% | -44.34% |
| % of Gross Profit | 106.24% | 185.44% | 181.98% |
| Depreciation & Amortization | $1.016M | $2.470M | $10.31M |
| YoY Change | -43.49% | -15.7% | -16.99% |
| % of Gross Profit | 22.33% | 51.88% | 59.36% |
| Operating Expenses | $13.47M | $19.38M | $73.07M |
| YoY Change | -36.19% | -18.1% | -38.5% |
| Operating Profit | -$6.396M | -$14.62M | -$41.15M |
| YoY Change | -33.58% | -32.11% | 34.85% |
| Interest Expense | $10.00K | $10.00K | $13.00K |
| YoY Change | -66.67% | -75.0% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | $118.0K | -$20.00K | $304.0K |
| YoY Change | 38.82% | 100.0% | -6.75% |
| Pretax Income | -$6.505M | -$9.858M | -$41.70M |
| YoY Change | -32.86% | -37.25% | 36.32% |
| Income Tax | -$130.0K | -$50.00K | -$87.00K |
| % Of Pretax Income | |||
| Net Earnings | -$6.375M | -$9.813M | -$41.30M |
| YoY Change | -33.75% | -36.85% | 33.85% |
| Net Earnings / Revenue | -90.12% | -103.02% | -129.39% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$165.7K | -$252.1K | -$1.081M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 38.40M shares | 38.11M shares | 38.23M shares |
| Diluted Shares Outstanding | 38.23M shares |
Balance Sheet
| Concept | 2014 Q1 | 2013 Q4 | 2013 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $24.17M | $25.14M | $25.10M |
| YoY Change | -45.3% | -44.79% | -44.84% |
| Cash & Equivalents | $23.16M | $22.13M | $22.10M |
| Short-Term Investments | $1.002M | $3.005M | $3.000M |
| Other Short-Term Assets | $3.100M | $3.800M | $3.800M |
| YoY Change | -24.39% | -29.63% | -29.63% |
| Inventory | $2.045M | $1.487M | $1.500M |
| Prepaid Expenses | |||
| Receivables | $4.907M | $5.413M | $5.400M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $34.24M | $35.78M | $35.80M |
| YoY Change | -40.31% | -40.13% | -40.13% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $7.396M | $8.446M | $8.400M |
| YoY Change | -50.0% | -49.27% | -49.7% |
| Goodwill | $3.241M | $3.241M | |
| YoY Change | 0.0% | 0.0% | |
| Intangibles | $8.716M | $9.560M | |
| YoY Change | -27.91% | -26.09% | |
| Long-Term Investments | $1.400M | $800.0K | $800.0K |
| YoY Change | -26.32% | -77.78% | -77.78% |
| Other Assets | $208.0K | $306.0K | $1.000M |
| YoY Change | -92.3% | -86.32% | -72.97% |
| Total Long-Term Assets | $21.72M | $23.06M | $23.00M |
| YoY Change | -40.13% | -42.63% | -42.79% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $34.24M | $35.78M | $35.80M |
| Total Long-Term Assets | $21.72M | $23.06M | $23.00M |
| Total Assets | $55.96M | $58.84M | $58.80M |
| YoY Change | -40.24% | -41.14% | -41.2% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $3.487M | $3.961M | $4.000M |
| YoY Change | -21.55% | 8.4% | 8.11% |
| Accrued Expenses | $2.699M | $1.612M | $5.200M |
| YoY Change | -44.07% | -76.8% | -50.0% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $13.09M | $11.20M | $11.20M |
| YoY Change | -26.36% | -31.22% | -31.29% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $4.900M | $5.044M | $6.200M |
| YoY Change | 26.68% | 27.92% | 19.23% |
| Total Long-Term Liabilities | $4.900M | $5.044M | $6.200M |
| YoY Change | 26.68% | 27.92% | 19.23% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $13.09M | $11.20M | $11.20M |
| Total Long-Term Liabilities | $4.900M | $5.044M | $6.200M |
| Total Liabilities | $19.39M | $17.36M | $17.40M |
| YoY Change | -10.42% | -14.18% | -19.07% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$263.2M | -$256.9M | |
| YoY Change | 16.9% | 19.16% | |
| Common Stock | $4.000K | $4.000K | |
| YoY Change | 0.0% | 0.0% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $36.57M | $41.48M | $41.50M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $55.96M | $58.84M | $58.80M |
| YoY Change | -40.24% | -41.14% | -41.2% |
Cashflow Statement
| Concept | 2014 Q1 | 2013 Q4 | 2013 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$6.375M | -$9.813M | -$41.30M |
| YoY Change | -33.75% | -36.85% | 33.85% |
| Depreciation, Depletion And Amortization | $1.016M | $2.470M | $10.31M |
| YoY Change | -43.49% | -15.7% | -16.99% |
| Cash From Operating Activities | -$2.405M | -$3.910M | -$23.00M |
| YoY Change | -31.03% | -17.34% | 93.39% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $21.00K | -$730.0K | $1.175M |
| YoY Change | -56.25% | 143.33% | -59.94% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $3.630M | $290.0K | $14.45M |
| YoY Change | 45.2% | -97.39% | -26.43% |
| Cash From Investing Activities | $3.606M | -$440.0K | $13.27M |
| YoY Change | 47.06% | -104.07% | -20.58% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $0.00 | ||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -$168.0K | -440.0K | -$147.0K |
| YoY Change | -163.88% | -218.92% | -111.69% |
| NET CHANGE | |||
| Cash From Operating Activities | -$2.405M | -3.910M | -$23.00M |
| Cash From Investing Activities | $3.606M | -440.0K | $13.27M |
| Cash From Financing Activities | -$168.0K | -440.0K | -$147.0K |
| Net Change In Cash | $1.033M | -4.790M | -$9.873M |
| YoY Change | -233.81% | -174.38% | -262.49% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$2.405M | -$3.910M | -$23.00M |
| Capital Expenditures | $21.00K | -$730.0K | $1.175M |
| Free Cash Flow | -$2.426M | -$3.180M | -$24.17M |
| YoY Change | -31.37% | -28.22% | 63.06% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
5040000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4366000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3961000 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3654000 | USD |
| CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5413000 | USD |
| CY2012Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7545000 | USD |
| CY2011 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-771000 | USD |
| CY2013 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-42000 | USD |
| CY2012 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-697000 | USD |
| CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
6948000 | USD |
| CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1612000 | USD |
| CY2012Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
34172000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
29461000 | USD |
| CY2013 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
|
6944000 | USD |
| CY2011 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
|
7755000 | USD |
| CY2012 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
|
8908000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-32000 | USD |
| CY2010Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
128000 | USD |
| CY2012Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-136000 | USD |
| CY2011Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-242000 | USD |
| CY2010Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
|
-162000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
|
0 | USD |
| CY2011Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
|
-165000 | USD |
| CY2012Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
|
0 | USD |
| CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-32000 | USD |
| CY2012Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-136000 | USD |
| CY2011Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-407000 | USD |
| CY2010Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-34000 | USD |
| CY2012Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
294128000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
298370000 | USD |
| CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
9286000 | USD |
| CY2011 | us-gaap |
Advertising Expense
AdvertisingExpense
|
113000 | USD |
| CY2012 | us-gaap |
Advertising Expense
AdvertisingExpense
|
351000 | USD |
| CY2013 | us-gaap |
Advertising Expense
AdvertisingExpense
|
513000 | USD |
| CY2012 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
7351000 | shares |
| CY2013 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1571000 | USD |
| CY2013Q4 | us-gaap |
Asset Retirement Obligation
AssetRetirementObligation
|
109000 | USD |
| CY2011 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
39000 | USD |
| CY2013 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
0 | USD |
| CY2012 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
30000 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
58840000 | USD |
| CY2012Q4 | us-gaap |
Assets
Assets
|
99965000 | USD |
| CY2011Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
17000 | USD |
| CY2010Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
58000 | USD |
| CY2012Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
150000 | USD |
| CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
460000 | USD |
| CY2012 | us-gaap |
Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
|
0 | USD |
| CY2011 | us-gaap |
Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
|
0 | USD |
| CY2013 | us-gaap |
Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
|
0 | USD |
| CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
460000 | USD |
| CY2012Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
150000 | USD |
| CY2012 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
0 | USD |
| CY2011 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
0 | USD |
| CY2013 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
76000 | USD |
| CY2012 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3509000 | USD |
| CY2013 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3374000 | USD |
| CY2011 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3716000 | USD |
| CY2011 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8716000 | shares |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6797000 | shares |
| CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
59769000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
35781000 | USD |
| CY2013Q4 | us-gaap |
Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
|
2179000 | USD |
| CY2012Q4 | us-gaap |
Assets Held For Sale Current
AssetsHeldForSaleCurrent
|
0 | USD |
| CY2013Q4 | us-gaap |
Assets Held For Sale Current
AssetsHeldForSaleCurrent
|
2179000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
19654000 | USD |
| CY2012Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
41874000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
|
19889000 | USD |
| CY2012Q4 | us-gaap |
Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
|
41937000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
|
0 | USD |
| CY2012Q4 | us-gaap |
Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
|
0 | USD |
| CY2013Q4 | us-gaap |
Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
|
235000 | USD |
| CY2012Q4 | us-gaap |
Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
|
63000 | USD |
| CY2013Q4 | us-gaap |
Cash
Cash
|
6041000 | USD |
| CY2012Q4 | us-gaap |
Cash
Cash
|
7214000 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
22130000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
32003000 | USD |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
25762000 | USD |
| CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
72396000 | USD |
| CY2011 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-46634000 | USD |
| CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
6241000 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-9873000 | USD |
| CY2012Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
6066 | shares |
| CY2013Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
0 | shares |
| CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
38351000 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
37692000 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
37692000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
38351000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4000 | USD |
| CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4000 | USD |
| CY2013 | us-gaap |
Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time the Company reclassifies certain prior period balances to conform to the current year presentation. These include revenue amounts reclassified and split out into additional categories. These reclassifications had no material impact on previously reported total assets, total liabilities, stockholders’ equity, results of operations or cash flows.</font></div></div> | |
| CY2012 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-30586000 | USD |
| CY2011 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-16923000 | USD |
| CY2013 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-41199000 | USD |
| CY2013 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk/Major Customers</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, accounts receivable and restricted cash. Cash and cash equivalents, marketable securities and restricted cash are invested through banks and other financial institutions in the United States, as well as in other foreign countries. Such deposits may be in excess of insured limits.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit risk with respect to accounts receivable exists to the full extent of amounts presented in the consolidated financial statements. The Company periodically requires collateral to support credit sales. The Company estimates an allowance for doubtful accounts through specific identification of potentially uncollectible accounts receivable based on an analysis of its accounts receivable aging. Uncollectible accounts receivable are written off against the allowance for doubtful accounts when all efforts to collect them have been exhausted. Recoveries are recognized when they are received. Actual collection losses may differ from the Company's estimates and could be material to the Company's consolidated financial position, results of operations, and cash flows.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's top five customers accounted for </font><font style="font-family:inherit;font-size:10pt;">81%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">83%</font><font style="font-family:inherit;font-size:10pt;"> of the Company's total revenues for the twelve months ended December 31, 2013 and 2012, respectively. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customers with revenues of </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of the Company's total revenues consist of the following:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Percentage of Total Revenues</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">For The Years Ended December  31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2011</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customers:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Merck</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exela</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Novartis</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shell</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Novartis had a balance of </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> of the Company's accounts receivable as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">. Merck had a balance of </font><font style="font-family:inherit;font-size:10pt;">53%</font><font style="font-family:inherit;font-size:10pt;"> and Novartis had a balance of </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of the Company’s accounts receivable as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2012</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2013, the Company recorded an allowance for bad debt of approximately </font><font style="font-family:inherit;font-size:10pt;">$387,000</font><font style="font-family:inherit;font-size:10pt;"> due to a write-off of an accounts receivable from Arch Pharmalabs Limited ("Arch"). </font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Supply Risk</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company relies on a limited number of suppliers for its products. The Company believes that other vendors would be able to provide similar products; however, the qualification of such vendors may require substantial start-up time. In order to mitigate any adverse impacts from a disruption of supply, the Company attempts to maintain an adequate supply of critical single-sourced materials. For certain materials, the Company's vendors maintain a supply for the Company. The Company outsources the commercial scale manufacturing of its products to contract manufacturers with facilities in Austria, India and Italy.</font></div></div> | |
| CY2013 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
14554000 | USD |
| CY2012 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
30647000 | USD |
| CY2011 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
41781000 | USD |
| CY2013Q3 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
494000 | USD |
| CY2013Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
5665000 | USD |
| CY2012Q3 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
6397000 | USD |
| CY2013Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
3631000 | USD |
| CY2013Q4 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
4764000 | USD |
| CY2012Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
12642000 | USD |
| CY2012Q4 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
5779000 | USD |
| CY2012Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
5829000 | USD |
| CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2011 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
3000 | USD |
| CY2012 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2012 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
178000 | USD |
| CY2011 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
82000 | USD |
| CY2013 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
-45000 | USD |
| CY2011 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
92000 | USD |
| CY2013 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
-40000 | USD |
| CY2012 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
185000 | USD |
| CY2013 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
5000 | USD |
| CY2011 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
7000 | USD |
| CY2012 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
7000 | USD |
| CY2011 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-59000 | USD |
| CY2012 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-62000 | USD |
| CY2013 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
19000 | USD |
| CY2011 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
149000 | USD |
| CY2012 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
154000 | USD |
| CY2011 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
149000 | USD |
| CY2012 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
85000 | USD |
| CY2013 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-47000 | USD |
| CY2012Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
2001000 | USD |
| CY2012Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
2186000 | USD |
| CY2012Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
1299000 | USD |
| CY2013Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
1114000 | USD |
| CY2013 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-7000 | USD |
| CY2012 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-7000 | USD |
| CY2011 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
1198000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
1297000 | USD |
| CY2012Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.41 | |
| CY2013Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.33 | |
| CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.25 | |
| CY2012Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.06 | |
| CY2012Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.15 | |
| CY2013Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.24 | |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
4208000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
3556000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
86294000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
71712000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
|
166000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
|
112000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
20000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
54923000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
67507000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
141000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
159000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
2247000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
1746000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
3329000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
4194000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
|
3626000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
|
2090000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
3043000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
4464000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
0 | USD |
| CY2011 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.46 | |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.08 | |
| CY2012 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.84 | |
| CY2013Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.26 | |
| CY2012Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.21 | |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
9560000 | USD |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
12934000 | USD |
| CY2013 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
0 | USD |
| CY2011 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
85000 | USD |
| CY2012 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
165000 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3625000 | USD |
| CY2012Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3495000 | USD |
| CY2013Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
2177000 | USD |
| CY2013 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y7M27D | |
| CY2013 | us-gaap |
Entity Wide Revenue Major Customer Percentage
EntityWideRevenueMajorCustomerPercentage
|
0.10 | |
| CY2013 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P6Y | |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
11942000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
15316000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
3374000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
2812000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
3374000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
24876000 | USD |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
24876000 | USD |
| CY2012 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-348000 | USD |
| CY2013 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-305000 | USD |
| CY2011 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-706000 | USD |
| CY2013 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-1582000 | USD |
| CY2011 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-49000 | USD |
| CY2012 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-1551000 | USD |
| CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
3241000 | USD |
| CY2012Q4 | us-gaap |
Goodwill
Goodwill
|
3241000 | USD |
| CY2012 | us-gaap |
Impairment Of Investments
ImpairmentOfInvestments
|
753000 | USD |
| CY2013Q4 | us-gaap |
Incentive From Lessor
IncentiveFromLessor
|
2160000 | USD |
| CY2011 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-16309000 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-41390000 | USD |
| CY2012 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-30587000 | USD |
| CY2012Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-7293000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-9688000 | USD |
| CY2012Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-5442000 | USD |
| CY2013Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-9858000 | USD |
| CY2012Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-15711000 | USD |
| CY2012Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-2140000 | USD |
| CY2013Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-9227000 | USD |
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-12617000 | USD |
| CY2012 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
270000 | USD |
| CY2011 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
241000 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-87000 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
17392000 | USD |
| CY2011 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
5814000 | USD |
| CY2012 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
9716000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1629000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-11372000 | USD |
| CY2011 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
89000 | USD |
| CY2012 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
126000 | USD |
| CY2013 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
103000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-6710000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
308000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1156000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
3583000 | USD |
| CY2012 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
1493000 | USD |
| CY2011 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
0 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
0 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
-108000 | USD |
| CY2011 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
-252000 | USD |
| CY2012 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
7000 | USD |
| CY2012 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-10399000 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-14073000 | USD |
| CY2011 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-5708000 | USD |
| CY2011 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
|
650000 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
|
-1272000 | USD |
| CY2012 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
|
204000 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
117000 | USD |
| CY2012 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
312000 | USD |
| CY2011 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
1241000 | USD |
| CY2012 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-1063000 | USD |
| CY2011 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-1421000 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-1948000 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
195000 | USD |
| CY2012 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
0 | USD |
| CY2011 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
83000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
|
0 | USD |
| CY2012 | us-gaap |
Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
|
0 | USD |
| CY2013 | us-gaap |
Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
|
2179000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1789000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-4339000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
1629000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-1322000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-3290000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
130000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
185000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-3186000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1671000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
4351000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
197000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-2724000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-337000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-513000 | USD |
| CY2012 | us-gaap |
Interest Expense
InterestExpense
|
0 | USD |
| CY2013 | us-gaap |
Interest Expense
InterestExpense
|
13000 | USD |
| CY2012Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
662000 | USD |
| CY2013Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
693000 | USD |
| CY2012Q4 | us-gaap |
Inventory Net
InventoryNet
|
1302000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
1330000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | USD |
| CY2011 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
1857000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-850000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
682000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
3051000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
45000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2013 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-800000 | USD |
| CY2011 | us-gaap |
Interest Expense
InterestExpense
|
0 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
1487000 | USD |
| CY2013Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
763000 | USD |
| CY2012Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
588000 | USD |
| CY2012Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
52000 | USD |
| CY2013Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
31000 | USD |
| CY2011 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
273000 | USD |
| CY2013 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
60000 | USD |
| CY2012 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
252000 | USD |
| CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
99965000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
58840000 | USD |
| CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
16283000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11199000 | USD |
| CY2013Q4 | us-gaap |
Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
|
600000 | USD |
| CY2013Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
3005000 | USD |
| CY2011 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2579000 | USD |
| CY2011 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-48808000 | USD |
| CY2012Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
13524000 | USD |
| CY2012Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
3623000 | USD |
| CY2013Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
795000 | USD |
| CY2012Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
24789000 | USD |
| CY2013Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
16089000 | USD |
| CY2013 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of Business</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Codexis, Inc. (the “Company”) was incorporated in the State of Delaware in January 2002. The Company develops biocatalysts for the pharmaceutical and fine chemicals markets. Its proven technologies enable scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development, from research to manufacturing. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Biocatalysts are enzymes or microbes that initiate and/or accelerate chemical reactions. Manufacturers have historically used naturally occurring biocatalysts to produce many goods used in everyday life. However, inherent limitations in naturally occurring biocatalysts have restricted their commercial use. The Company’s proprietary technology platform is able to overcome many of these limitations, allowing us to evolve and optimize biocatalysts to perform specific and desired chemical reactions at commercial scale. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has commercialized its technology and products in the pharmaceuticals market, which is the Company’s primary business focus. The Company’s pharmaceutical customers, which include several of the largest global pharmaceutical companies, use the Company’s technology, products and services in their manufacturing process development, including in the production of some of the world's bestselling and fastest growing drugs. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recently begun to use its technology to develop biocatalysts for use in the fine chemicals markets. The fine chemicals market is similar to the Company’s pharmaceutical business and consists of several large market segments, including food, animal feed, polymers, flavors and fragrances and agricultural chemicals, and so it is a natural fit for the Company’s technology.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company creates its products by applying its CodeEvolver</font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> directed evolution technology platform, which introduces genetic mutations into microorganisms, giving rise to changes in the enzymes that they produce. Once the Company identifies potentially beneficial mutations, it tests combinations of these mutations until it has created variant enzymes that exhibit marketable performance characteristics superior to competitive products. This process allows the Company to make continuous, efficient improvements to the performance of its enzymes.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In these Notes to Consolidated Financial Statements, the “Company” refers to Codexis, Inc. and its subsidiaries on a consolidated basis.</font></div></div> | |
| CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1257000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-147000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
16711000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
13272000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-11892000 | USD |
| CY2011 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-490000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-22998000 | USD |
| CY2011 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-16550000 | USD |
| CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-30857000 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-41303000 | USD |
| CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9623000 | USD |
| CY2012Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15538000 | USD |
| CY2012Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5519000 | USD |
| CY2012Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2309000 | USD |
| CY2013Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9813000 | USD |
| CY2012Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7490000 | USD |
| CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12605000 | USD |
| CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9262000 | USD |
| CY2013Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
18312000 | USD |
| CY2012Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
31821000 | USD |
| CY2011 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-15907000 | USD |
| CY2011Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
41592000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
17551000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
2968000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
2736000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
2677000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
3063000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
3053000 | USD |
| CY2012Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
38386000 | USD |
| CY2012Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
23659000 | USD |
| CY2013Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
21111000 | USD |
| CY2013Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
19376000 | USD |
| CY2012Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
28268000 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-41146000 | USD |
| CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-30513000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
3054000 | USD |
| CY2012Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | operating_segment |
| CY2013 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
73068000 | USD |
| CY2011 | us-gaap |
Operating Expenses
OperatingExpenses
|
139772000 | USD |
| CY2012 | us-gaap |
Operating Expenses
OperatingExpenses
|
118811000 | USD |
| CY2013Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
13157000 | USD |
| CY2013Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
19424000 | USD |
| CY2012Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
28497000 | USD |
| CY2013 | us-gaap |
Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
|
309000 | USD |
| CY2012Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
2237000 | USD |
| CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
306000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
165000 | USD |
| CY2013 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
0 | USD |
| CY2011 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-3000 | USD |
| CY2013 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
104000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
271000 | USD |
| CY2011 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-373000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment For Writedown Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax
|
753000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-647000 | USD |
| CY2013 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
104000 | USD |
| CY2011 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-370000 | USD |
| CY2012 | us-gaap |
Other Expenses
OtherExpenses
|
326000 | USD |
| CY2013 | us-gaap |
Other Expenses
OtherExpenses
|
304000 | USD |
| CY2011 | us-gaap |
Other Expenses
OtherExpenses
|
675000 | USD |
| CY2012Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
3943000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
5044000 | USD |
| CY2013 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
-14000 | USD |
| CY2012 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
-22000 | USD |
| CY2011 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
-31000 | USD |
| CY2013 | us-gaap |
Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
|
0 | USD |
| CY2013 | us-gaap |
Payments For Rent
PaymentsForRent
|
2587000 | USD |
| CY2011 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | USD |
| CY2012 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | USD |
| CY2013 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
465000 | USD |
| CY2011 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
52564000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
0 | USD |
| CY2012 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
20638000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2933000 | USD |
| CY2011 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
10736000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1175000 | USD |
| CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2012Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2012Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2012Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2012Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Value Outstanding
PreferredStockValueOutstanding
|
0 | USD |
| CY2012Q4 | us-gaap |
Preferred Stock Value Outstanding
PreferredStockValueOutstanding
|
0 | USD |
| CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1567000 | USD |
| CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
5395000 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
68000 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
0 | USD |
| CY2011 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
0 | USD |
| CY2011 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
8500000 | USD |
| CY2013 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
13409000 | USD |
| CY2012 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
29885000 | USD |
| CY2013 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
238000 | USD |
| CY2012 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | USD |
| CY2011 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | USD |
| CY2011 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2579000 | USD |
| CY2012 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1257000 | USD |
| CY2013 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
318000 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
50822000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
37907000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
8446000 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
16650000 | USD |
| CY2013 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
386000 | USD |
| CY2012 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
133000 | USD |
| CY2011 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-41000 | USD |
| CY2011 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
70918000 | USD |
| CY2012 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
49977000 | USD |
| CY2013 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
6868000 | USD |
| CY2013Q3 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
2028000 | USD |
| CY2011 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
61049000 | USD |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
31606000 | USD |
| CY2012Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
10594000 | USD |
| CY2013Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7322000 | USD |
| CY2012Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
14191000 | USD |
| CY2013Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6831000 | USD |
| CY2013Q4 | us-gaap |
Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
|
711000 | USD |
| CY2012Q4 | us-gaap |
Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
|
1511000 | USD |
| CY2013Q1 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
1300000 | USD |
| CY2012Q4 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
1078000 | USD |
| CY2012Q3 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
18569000 | USD |
| CY2012Q1 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
14362000 | USD |
| CY2012Q2 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
15868000 | USD |
| CY2013Q4 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
1931000 | USD |
| CY2013Q2 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
1609000 | USD |
| CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
56785000 | USD |
| CY2013Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8624000 | USD |
| CY2012Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
16349000 | USD |
| CY2012Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
15650000 | USD |
| CY2013Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8829000 | USD |
| CY2013 | us-gaap |
Restructuring Charges
RestructuringCharges
|
809000 | USD |
| CY2012 | us-gaap |
Restructuring Charges
RestructuringCharges
|
3109000 | USD |
| CY2012Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
420000 | USD |
| CY2013Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
277000 | USD |
| CY2013 | us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
-26000 | USD |
| CY2012 | us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
-153000 | USD |
| CY2013 | us-gaap |
Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
|
877000 | USD |
| CY2012 | us-gaap |
Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
|
1123000 | USD |
| CY2012 | us-gaap |
Restructuring Reserve Settled Without Cash
RestructuringReserveSettledWithoutCash
|
1413000 | USD |
| CY2013 | us-gaap |
Restructuring Reserve Settled Without Cash
RestructuringReserveSettledWithoutCash
|
49000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-256859000 | USD |
| CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-215556000 | USD |
| CY2011 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
3476000 | USD |
| CY2012 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
2247000 | USD |
| CY2013 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
0 | USD |
| CY2013Q4 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
0 | USD |
| CY2012Q1 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
1357000 | USD |
| CY2012Q3 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
632000 | USD |
| CY2013Q3 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
0 | USD |
| CY2012Q4 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
0 | USD |
| CY2013Q1 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
1044000 | USD |
| CY2013Q1 | us-gaap |
Revenues
Revenues
|
11480000 | USD |
| CY2013Q2 | us-gaap |
Revenues
Revenues
|
6974000 | USD |
| CY2013Q2 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
417000 | USD |
| CY2012Q4 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
0 | USD |
| CY2013Q3 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
839000 | USD |
| CY2012Q2 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
0 | USD |
| CY2013Q1 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
0 | USD |
| CY2012Q2 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
258000 | USD |
| CY2013Q2 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
0 | USD |
| CY2012 | us-gaap |
Revenues
Revenues
|
88298000 | USD |
| CY2011 | us-gaap |
Revenues
Revenues
|
123865000 | USD |
| CY2013 | us-gaap |
Revenues
Revenues
|
31922000 | USD |
| CY2012Q4 | us-gaap |
Revenues
Revenues
|
7912000 | USD |
| CY2012Q3 | us-gaap |
Revenues
Revenues
|
26341000 | USD |
| CY2013Q4 | us-gaap |
Revenues
Revenues
|
9525000 | USD |
| CY2013Q3 | us-gaap |
Revenues
Revenues
|
3943000 | USD |
| CY2012Q2 | us-gaap |
Revenues
Revenues
|
22909000 | USD |
| CY2012Q1 | us-gaap |
Revenues
Revenues
|
31136000 | USD |
| CY2011 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
450000 | USD |
| CY2013 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
4631000 | USD |
| CY2012 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
150000 | USD |
| CY2012Q3 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
0 | USD |
| CY2013Q4 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
2331000 | USD |
| CY2012Q1 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
250000 | USD |
| CY2011 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
49021000 | USD |
| CY2012 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
35924000 | USD |
| CY2013 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
20423000 | USD |
| CY2013Q2 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
4948000 | USD |
| CY2013Q4 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
5263000 | USD |
| CY2012Q1 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
15167000 | USD |
| CY2012Q3 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
7140000 | USD |
| CY2012Q4 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
6834000 | USD |
| CY2013Q1 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
9136000 | USD |
| CY2013Q3 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
1076000 | USD |
| CY2012Q2 | us-gaap |
Sales Revenue Goods Gross
SalesRevenueGoodsGross
|
6783000 | USD |
| CY2013 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
26908000 | USD |
| CY2011 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
36942000 | USD |
| CY2012 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
31379000 | USD |
| CY2013Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
8124000 | USD |
| CY2012Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
9395000 | USD |
| CY2013Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
5832000 | USD |
| CY2012Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6789000 | USD |
| CY2013Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
5783000 | USD |
| CY2013Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
7169000 | USD |
| CY2012Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
7286000 | USD |
| CY2012Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
7909000 | USD |
| CY2011 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
9431000 | USD |
| CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5076000 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4389000 | USD |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
3767000 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
4908000 | shares |
| CY2013Q4 | us-gaap |
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
|
663000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
|
3308 | shares |
| CY2011 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
2579000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
318000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1257000 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
78440000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
41483000 | USD |
| CY2012Q4 | us-gaap |
Valuation Allowance Amount
ValuationAllowanceAmount
|
71692000 | USD |
| CY2013Q4 | us-gaap |
Valuation Allowance Amount
ValuationAllowanceAmount
|
86294000 | USD |
| CY2013 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
14600000 | USD |
| CY2012 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
8600000 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
102690000 | USD |
| CY2010Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
107361000 | USD |
| CY2013Q4 | us-gaap |
Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
|
1300000 | USD |
| CY2011 | us-gaap |
Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
|
-370000 | USD |
| CY2013 | us-gaap |
Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
|
104000 | USD |
| CY2012 | us-gaap |
Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
|
-647000 | USD |
| CY2012Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
7420000 | USD |
| CY2011Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
6611000 | USD |
| CY2010Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
6492000 | USD |
| CY2013Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
8306000 | USD |
| CY2011 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
262000 | USD |
| CY2012 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
-24000 | USD |
| CY2013 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
78000 | USD |
| CY2012Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
250000 | USD |
| CY2013Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
280000 | USD |
| CY2012 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
11000 | USD |
| CY2011 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
39000 | USD |
| CY2013 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
29000 | USD |
| CY2012 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
709000 | USD |
| CY2011 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
470000 | USD |
| CY2013 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
1116000 | USD |
| CY2013 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
6000 | USD |
| CY2012 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
263000 | USD |
| CY2011 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
4000 | USD |
| CY2012 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
187000 | USD |
| CY2013 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
158000 | USD |
| CY2011 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
93000 | USD |
| CY2012Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
1500000 | USD |
| CY2013Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
1000000 | USD |
| CY2013 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company's management regularly assesses these estimates which primarily affect revenue recognition, the valuation of marketable securities and accounts receivable, intangible assets, goodwill arising out of business acquisitions, inventories, accrued liabilities, stock awards and the valuation allowances associated with deferred tax assets. Actual results could differ from those estimates and such differences may be material to the consolidated financial statements.</font></div></div> | |
| CY2011 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
5800000 | USD |
| CY2011 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
35674000 | shares |
| CY2013 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
38231000 | shares |
| CY2012 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
36768000 | shares |
| CY2012 | cdxs |
Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
|
165000 | USD |
| CY2012 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
36768000 | shares |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38231000 | shares |
| CY2011 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
35674000 | shares |
| CY2012Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
36296000 | shares |
| CY2012Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
37118000 | shares |
| CY2013Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38329000 | shares |
| CY2013Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38102000 | shares |
| CY2012Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
36057000 | shares |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
38060000 | shares |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
37842000 | shares |
| CY2012Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
37581000 | shares |
| CY2011 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
35674000 | shares |
| CY2012 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
36768000 | shares |
| CY2013 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
38231000 | shares |
| CY2013 | cdxs |
Adjustments To Additional Paid In Capital Non Employee Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalNonEmployeeShareBasedCompensation
|
23000 | USD |
| CY2011 | cdxs |
Adjustments To Additional Paid In Capital Non Employee Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalNonEmployeeShareBasedCompensation
|
387000 | USD |
| CY2013 | cdxs |
Defined Contribution Plan Minimum Employee Eligibility Age
DefinedContributionPlanMinimumEmployeeEligibilityAge
|
P18Y | |
| CY2012 | cdxs |
Exercise Of Common Warrants Shares
ExerciseOfCommonWarrantsShares
|
0 | shares |
| CY2011 | cdxs |
Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
|
-3000 | USD |
| CY2012 | cdxs |
Adjustments To Additional Paid In Capital Non Employee Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalNonEmployeeShareBasedCompensation
|
104000 | USD |
| CY2012 | cdxs |
Comprehensive Loss
ComprehensiveLoss
|
-30586000 | USD |
| CY2011 | cdxs |
Comprehensive Loss
ComprehensiveLoss
|
-16923000 | USD |
| CY2013 | cdxs |
Comprehensive Loss
ComprehensiveLoss
|
-41199000 | USD |
| CY2013 | cdxs |
Defined Contribution Plan Employer Contribution Amount
DefinedContributionPlanEmployerContributionAmount
|
488000 | USD |
| CY2012 | cdxs |
Defined Contribution Plan Employer Contribution Amount
DefinedContributionPlanEmployerContributionAmount
|
0 | USD |
| CY2011 | cdxs |
Defined Contribution Plan Employer Contribution Amount
DefinedContributionPlanEmployerContributionAmount
|
0 | USD |
| CY2013 | cdxs |
Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
|
0 | USD |
| CY2012 | cdxs |
Gain From Extinguishment Of Asset Retirement Obligation
GainFromExtinguishmentOfAssetRetirementObligation
|
-212000 | USD |
| CY2011 | cdxs |
Gain From Extinguishment Of Asset Retirement Obligation
GainFromExtinguishmentOfAssetRetirementObligation
|
-124000 | USD |
| CY2013 | cdxs |
Gain From Extinguishment Of Asset Retirement Obligation
GainFromExtinguishmentOfAssetRetirementObligation
|
0 | USD |
| CY2013 | cdxs |
Impairment Of Marketable Securities
ImpairmentOfMarketableSecurities
|
0 | USD |
| CY2012 | cdxs |
Impairment Of Marketable Securities
ImpairmentOfMarketableSecurities
|
753000 | USD |
| CY2011 | cdxs |
Impairment Of Marketable Securities
ImpairmentOfMarketableSecurities
|
0 | USD |
| CY2013 | cdxs |
Investment Maturity Period
InvestmentMaturityPeriod
|
P1Y | |
| CY2013 | cdxs |
Maturity Date Of Highly Liquid Investments
MaturityDateOfHighlyLiquidInvestments
|
P3M | |
| CY2012Q4 | cdxs |
Number Of Marketable Securities
NumberOfMarketableSecurities
|
0 | securities |
| CY2013Q4 | cdxs |
Number Of Marketable Securities
NumberOfMarketableSecurities
|
0 | securities |
| CY2012 | cdxs |
Other Comprehensive Income Lossbefore Reclassifications Netof Tax
OtherComprehensiveIncomeLossbeforeReclassificationsNetofTax
|
-482000 | USD |
| CY2013 | cdxs |
Ownership Percentage Threshold Under Stockholder Rights Plan
OwnershipPercentageThresholdUnderStockholderRightsPlan
|
0.15 | |
| CY2012 | cdxs |
Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
|
10397000 | USD |
| CY2011 | cdxs |
Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
|
6037000 | USD |
| CY2013 | cdxs |
Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
|
0 | USD |
| CY2013 | cdxs |
Reclassificationfrom Accumulated Other Comprehensive Income Current Period Netof Tax
ReclassificationfromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetofTax
|
0 | USD |
| CY2011 | cdxs |
Reclassificationfrom Accumulated Other Comprehensive Income Current Period Netof Tax
ReclassificationfromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetofTax
|
0 | USD |
| CY2012 | cdxs |
Reclassificationfrom Accumulated Other Comprehensive Income Current Period Netof Tax
ReclassificationfromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetofTax
|
753000 | USD |
| CY2013 | cdxs |
Share Based Compensation Arrangement By Share Based Payment Award Expiration Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
|
P10Y | |
| CY2013 | cdxs |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized During Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedDuringPeriod
|
1507000 | shares |
| CY2012 | cdxs |
Stock Issued During Period Value Cancellation
StockIssuedDuringPeriodValueCancellation
|
65000 | USD |
| CY2013 | cdxs |
Stock Issued During Period Value Cancellation
StockIssuedDuringPeriodValueCancellation
|
465000 | USD |
| CY2013Q4 | cdxs |
Tender Offer Portion Of Common Stock
TenderOfferPortionOfCommonStock
|
0.15 | |
| CY2013Q4 | cdxs |
Unrecognized Tax Benefits Expected To Be Recognized During Next Twelve Months
UnrecognizedTaxBenefitsExpectedToBeRecognizedDuringNextTwelveMonths
|
439000 | USD |
| CY2013 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2013 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2013 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2013 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
| CY2013 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-12-31 | |
| CY2013 | dei |
Document Type
DocumentType
|
10-K | |
| CY2013 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001200375 | |
| CY2014Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
38395862 | shares |
| CY2013 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2013 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
| CY2013Q2 | dei |
Entity Public Float
EntityPublicFloat
|
61200000 | USD |
| CY2013 | dei |
Entity Registrant Name
EntityRegistrantName
|
CODEXIS INC | |
| CY2013 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2013 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No |
